bendroflumethiazide has been researched along with albuterol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lipworth, BJ; McDevitt, DG; Struthers, AD | 3 |
1 review(s) available for bendroflumethiazide and albuterol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for bendroflumethiazide and albuterol
Article | Year |
---|---|
Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene.
Topics: Adult; Albuterol; Bendroflumethiazide; Drug Synergism; Electrocardiography; Female; Heart; Humans; Magnesium; Male; Potassium; Random Allocation; Single-Blind Method; Triamterene | 1990 |
Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene.
Topics: Adult; Albuterol; Bendroflumethiazide; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Humans; Hypokalemia; Spironolactone; Triamterene | 1990 |
Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol.
Topics: Administration, Inhalation; Adult; Albuterol; Bendroflumethiazide; Blood Pressure; Creatinine; Diuretics; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Electrocardiography; Electrolytes; Female; Heart Rate; Humans; Hypokalemia; Male | 1989 |
1 other study(ies) available for bendroflumethiazide and albuterol
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |